Lymphangioleiomyomatosis--presence of receptor tyrosine kinases and the angiogenesis factor VEGF-A as potential therapeutic targets
about
Lymphangioleiomyomatosis--presence of receptor tyrosine kinases and the angiogenesis factor VEGF-A as potential therapeutic targets
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Lymphangioleiomyomatosis--pres ...... potential therapeutic targets
@en
Lymphangioleiomyomatosis--pres ...... potential therapeutic targets
@nl
type
label
Lymphangioleiomyomatosis--pres ...... potential therapeutic targets
@en
Lymphangioleiomyomatosis--pres ...... potential therapeutic targets
@nl
prefLabel
Lymphangioleiomyomatosis--pres ...... potential therapeutic targets
@en
Lymphangioleiomyomatosis--pres ...... potential therapeutic targets
@nl
P2093
P2860
P356
P1433
P1476
Lymphangioleiomyomatosis--pres ...... potential therapeutic targets
@en
P2093
Detlef Kirsten
Helgo Magnussen
Henrik Watz
Knut Engels
Michael Amthor
Siegfried Loeschke
P2860
P356
10.1136/THX.2006.071811
P407
P577
2007-06-01T00:00:00Z